Changes in metabolic parameters in patients with severe mental illness over a 10-year period: A retrospective cohort study

Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial

(2015) P. Gardner-Sood et al.   PSYCHOLOGICAL MEDICINE

Cardiovascular Risk Prediction Models for People With Severe Mental Illness

(2015) David P. J. Osborn et al.   JAMA Psychiatry

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

(2015) MARC DE HERT et al.   World Psychiatry

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

(2015) MARC DE HERT et al.   World Psychiatry

Standard cardiovascular disease risk algorithms underestimate the risk of cardiovascular disease in schizophrenia: Evidence from a national primary care database

(2014) Gary McLean et al.   SCHIZOPHRENIA RESEARCH

Statins for primary prevention of cardiovascular disease

(2014) A. Majeed   BMJ-British Medical Journal

Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study

(2013) Casey Crump et al.   AMERICAN JOURNAL OF PSYCHIATRY

The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong – a cross sectional study

(2013) Daniel T Bressington et al.   BMC Psychiatry

A Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness

(2013) Gail L. Daumit et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening for Metabolic Risk Among Patients With Severe Mental Illness and Diabetes: A National Comparison

(2013) Alex J. Mitchell et al.   PSYCHIATRIC SERVICES

Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients

(2012) A. J. Mitchell et al.   SCHIZOPHRENIA BULLETIN

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

(2011) Goodarz Danaei et al.   LANCET

Cardiovascular Abnormalities in Patients with Major Depressive Disorder

(2009) Alex D.H. Brown et al.   CNS DRUGS

Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes

(2009) E. H. Morrato et al.   DIABETES CARE

Obesity, serious mental illness and antipsychotic drugs

(2009) Richard I. G. Holt et al.   DIABETES OBESITY & METABOLISM

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness

(2009) RIG Holt et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Creating medical and drug code lists to identify cases in primary care databases

(2009) Shreya Davé et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: Effect modification or regression to the mean?

(2009) David B. Allison et al.   PSYCHIATRY RESEARCH

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics

(2008) Christoph U Correll et al.   BIPOLAR DISORDERS

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis

(2008) M. Smith et al.   BRITISH JOURNAL OF PSYCHIATRY

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

(2008) Gail L. Daumit et al.   SCHIZOPHRENIA RESEARCH